{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T12:59:42Z","timestamp":1781269182221,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s10620-023-07920-6","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T07:02:30Z","timestamp":1680850950000},"page":"2597-2603","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Thromboembolic Events in Hospitalized Patients with Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6595-2534","authenticated-orcid":false,"given":"Alfred D.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Flux\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy","family":"Caldera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis A.","family":"Farraye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana G.","family":"Hashash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Kr\u00f6ner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,7]]},"reference":[{"key":"7920_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1001\/archinte.1936.00170110025002","volume":"58","author":"JA Bargen","year":"1936","unstructured":"Bargen JA, Barker NW. Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Archives of internal medicine. 1936;58:17\u201331.","journal-title":"Archives of internal medicine."},{"key":"7920_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1136\/gut.34.2.247","volume":"34","author":"MJ Webberley","year":"1993","unstructured":"Webberley MJ, Hart MT, Melikian V. Thromboembolism in inflammatory bowel disease: role of platelets. Gut. 1993;34:247\u2013251.","journal-title":"Gut."},{"key":"7920_CR3","first-page":"27","volume":"39","author":"OA Hatoum","year":"2005","unstructured":"Hatoum OA, Spinelli KS, Abu-Hajir M et al. Mesenteric venous thrombosis in inflammatory bowel disease. J Clin Gastroenterol. 2005;39:27\u201331.","journal-title":"J Clin Gastroenterol."},{"key":"7920_CR4","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1055\/s-0037-1615600","volume":"85","author":"CN Bernstein","year":"2001","unstructured":"Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thrombosis and haemostasis. 2001;85:430\u2013434.","journal-title":"Thrombosis and haemostasis."},{"key":"7920_CR5","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1111\/j.1572-0241.2008.02052.x","volume":"103","author":"GC Nguyen","year":"2008","unstructured":"Nguyen GC, Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. The American journal of gastroenterology. 2008;103:2272\u20132280.","journal-title":"The American journal of gastroenterology."},{"key":"7920_CR6","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/gut.2010.228585","volume":"60","author":"MD Kappelman","year":"2011","unstructured":"Kappelman MD, Horvath-Puho E, Sandler RS et al. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut. 2011;60:937\u2013943.","journal-title":"Gut."},{"key":"7920_CR7","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","volume":"375","author":"MJ Grainge","year":"2010","unstructured":"Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375:657\u2013663.","journal-title":"Lancet."},{"key":"7920_CR8","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/BF01536701","volume":"34","author":"BM Calkins","year":"1989","unstructured":"Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Digestive diseases and sciences. 1989;34:1841\u20131854.","journal-title":"Digestive diseases and sciences."},{"key":"7920_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1572-0241.2003.04026.x","volume":"99","author":"CA Solem","year":"2004","unstructured":"Solem CA, Loftus EV, Tremaine WJ, Sandborn WJ. Venous thromboembolism in inflammatory bowel disease. The American journal of gastroenterology. 2004;99:97\u2013101.","journal-title":"The American journal of gastroenterology."},{"key":"7920_CR10","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/ecco-jcc\/jjx162","volume":"12","author":"P Sarlos","year":"2018","unstructured":"Sarlos P, Szemes K, Hegyi P et al. Steroid but not Biological Therapy Elevates the risk of Venous Thromboembolic Events in Inflammatory Bowel Disease: A Meta-Analysis. Journal of Crohn\u2019s & colitis. 2018;12:489\u2013498.","journal-title":"Journal of Crohn's & colitis."},{"key":"7920_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41424-018-0013-8","volume":"9","author":"AR Andrade","year":"2018","unstructured":"Andrade AR, Barros LL, Azevedo MFC et al. Risk of thrombosis and mortality in inflammatory bowel disease. Clinical and translational gastroenterology. 2018;9:142\u2013142.","journal-title":"Clinical and translational gastroenterology."},{"key":"7920_CR12","doi-asserted-by":"publisher","first-page":"E1438","DOI":"10.1503\/cmaj.161485","volume":"189","author":"RJ Desai","year":"2017","unstructured":"Desai RJ, Gagne JJ, Lii J, Liu J, Friedman S, Kim SC. Comparative risk of incident venous thromboembolism in patients with inflammatory bowel disease initiating tumour necrosis factor-\u03b1 inhibitors or nonbiologic agents: a cohort study. Cmaj. 2017;189:E1438-e1447.","journal-title":"Cmaj."},{"key":"7920_CR13","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/0016-5085(95)90197-3","volume":"108","author":"NP Thompson","year":"1995","unstructured":"Thompson NP, Wakefield AJ, Pounder RE. Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology. 1995;108:1011\u20131015.","journal-title":"Gastroenterology."},{"key":"7920_CR14","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1053\/j.gastro.2014.01.042","volume":"146","author":"GC Nguyen","year":"2014","unstructured":"Nguyen GC, Bernstein CN, Bitton A et al. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology. Gastroenterology. 2014;146:835-848.e836.","journal-title":"Gastroenterology."},{"key":"7920_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.crohns.2012.09.005","volume":"7","author":"G Van Assche","year":"2013","unstructured":"Van Assche G, Dignass A, Bokemeyer B et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis. 2013;7:1\u201333.","journal-title":"J Crohns Colitis."},{"key":"7920_CR16","unstructured":"Project HCaU. Introduction to the NIS. City;2016."},{"key":"7920_CR17","unstructured":"Project HCaU. NIS Description of Data Elements. City; Agency for Healthcare Research and Quality;2008."},{"key":"7920_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of Clinical Epidemiology. 1992;45:613\u2013619.","journal-title":"Journal of Clinical Epidemiology."},{"key":"7920_CR19","first-page":"3372","volume":"130","author":"JB Cohen","year":"2017","unstructured":"Cohen JB, Ragni MV, Comer DM, Yabes JG. Inflammatory Bowel Disease and Thrombosis: A National Inpatient Sample (NIS) Study. Blood. 2017;130:3372\u20133372.","journal-title":"Blood."},{"key":"7920_CR20","doi-asserted-by":"crossref","unstructured":"Yuhara H, Steinmaus C, Corley D et al. Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease. 2013;37:953\u2013962.","DOI":"10.1111\/apt.12294"},{"key":"7920_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.amjsurg.2014.08.026","volume":"210","author":"M-S Tsai","year":"2015","unstructured":"Tsai M-S, Lin C-L, Chen H-P, Lee P-H, Sung F-C, Kao C-H. Long-term risk of mesenteric ischemia in patients with inflammatory bowel disease: a 13-year nationwide cohort study in an Asian population. The American Journal of Surgery. 2015;210:80\u201386.","journal-title":"The American Journal of Surgery."},{"key":"7920_CR22","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/pds.2334","volume":"21","author":"K Moores","year":"2012","unstructured":"Moores K, Gilchrist B, Carnahan R, Abrams T. A systematic review of validated methods for identifying pancreatitis using administrative data. Pharmacoepidemiology and drug safety. 2012;21:194\u2013202.","journal-title":"Pharmacoepidemiology and drug safety."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-07920-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-023-07920-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-07920-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T04:33:49Z","timestamp":1684211629000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-023-07920-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,7]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["7920"],"URL":"https:\/\/doi.org\/10.1007\/s10620-023-07920-6","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,7]]},"assertion":[{"value":"22 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Freddy Caldera has received research support from Takeda Pharmaceuticals and Sanofi. He has been a consultant for Takeda and Celgene. Dr. Farraye has served on advisory boards for BMS, Braintree Labs, Fresenius Kabi, GI Reviewers, Glaxo Smith Kline, Iterative Health, Janssen, Pfizer and Sebela. Dr. Farraye serves on a data Safety Monitoring Board for Adiso Therapeutics and Lilly.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}